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1 Introduction
Nutritional and immunological requirements for
growth and development of preterm infants are
under continuous investigation [4, 6]. There are
many reports stating that milk produced by
mothers of term infants provides all the necessary
nutritional requirements.
Recent reports have suggested that preterm infants
may benefit from their mother's milk for their
nutritional and immunological adaptation. Milk
obtained from mothers of preterm neonates has
increased contents of protein, fat, sodium and
chloride, and lower concentration of lactose when
compared with that of mothers of full term babies
[1, 3, 8, 9]. The composition of saturated and
unsaturated fatty acids is the same [14].
Besides its nutritional components, human milk
contains many factors with bacteriostatic effects
on the growth of many bacterial species including
E. Coli [7, 10, 15]. Secretory IgA plays a major
role in the protection of neonates from infec-
tion. In a longitudinal study of the effect of pre-
maturity on the development of several com-
ponents of the immunological system GOLDMAN
[5] found that the concentration of lactoferrin
and lysozyme were greater in preterm than in
term infants. The secretory IgA was the pre-
dominant form in preterm mother's milk.
It is common in many obstetrical clinics to treat
threatened premature labor by inhibiting uterine
contractility with a betamimetic drug along with
Curriculum vitae
MIGUEL MARTELL was
born in Uruguay in 1939.
He received his Doctor of
Medicine degree from the
School of Medicine,
University of Uruguay,
Montevideo, Uruguay, in
1970. He specialized in
pediatrics and works exclu-
sively in neonatology. His
main interest is in the field
of growth, development
arid feeding of neonates
which are preterm and low birth weight for gestational
age. His work has been performed at the Latin American
Center of Perinatology and Human Development (CLAP-
PAHO/WHO) and at the Newborn Unit of the Hospital de
Clinicas.
the administration of a glucocorticoid agent to
prevent the respiratory distress syndrome in the
neonate [11]. The aim of this study has been to
find if these drugs given to mothers who delivered
preterm infants had any influence on the secretory
IgA concentration of maternal milk.
2 Material and methods
Milk samples from three groups of mothers have
been studied.
Group I: 11 mothers who delivered preterm
neonates between 27 and 36 weeks of gestation
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and not receiving any medication prior to delivery.
Group II: 10 mothers whose delivery occurred
between 27 and 36 weeks gestational age and who
received Fenoterol between 1 and4Mg/minute I.V.
or 20 mg daily orally, during 48 hours before
delivery and a glucocorticoid agent (at least two
doses of betametasone, 12 mg I.M., 48 and
24 hours before delivery).
Group III: 11 mothers giving birth at between
38 and 40 weeks of gestational age were considered
as control group.
All the mothers aged between 18 and 32 years,
were in apparently good health, good nutritional
state and had no local inflammation of the breast.
The ratio of nulliparous and multiparous women
as well as the ratio of boys and girls in the off-
spring of each group were approximately equal.
All mothers had ruptured membranes twelve or
less hours before delivery. Gestational age was
determined from the last menstrual period and
by physical and neurological examination of the
newborn. When the difference was greater than
15 days, the mothers were not admitted to the
study.
The milk samples were collected with the follow-
ing method: At 8 a.m. mechanical emptying of
both breasts was performed and the milk was
discarded. After three hours (11 a.m.) the same
procedure was used to empty both breasts. This
was done to establish a definite period of time
and to avoid possible changes in concentration
which may occur during the night. The milk from
both breasts was mixed, the volume measured and
an aliquot was removed and stored at — 20°C.
The secretory IgA determination was performed
between 20 and 30 days after obtaining the
samples.
In each mother, the milk sample was obtained
at three periods after delivery. The first one
was collected between the 4th and 5th day, the
second between the 8th and 10th day, and the last
between the 14th and 15th day. Milk was not
studied in the first three days after delivery,
because mothers of preterm infants have little milk
secretion at this time due to the fact that these
infants are frequently nourished parenterally at
this moment.
The quantitative determination of secretory IgA
was carried out by the radial immunodiffusion
technique of MANCINI et al. [13] using a specific
antibody against the secretory piece (Bering
Institute). The secretory IgA used for the refer-
ence standard was isolated and purified from
colostrum and its protein concentration measured
by microbiuret. All samples assayed, including the
standard, were done in duplicate. A linear regres-
sion analysis was performed (r2 = 0.94).
The analysis of variance was used to assess the
concentration within the groups in every period
studied. The STUDENT'S paired test was used for
the analysis of the evolution of the secretoy IgA
concentration in each group at the different study
periods.
3 Results
The gestational age in the preterm groups is shown
in Tab. I. There was no significant difference
between both groups, with and without drugs.
Tab. II shows the concentration in the secretory
IgA in the three groups.
The secretory IgA concentration in mothers who
delivered at term was not significantly different, at
any of the three periods, from mothers delivering
preterm infants having or having not received
glucocorticoid and betamimetic therapy (Fig. 1).
The concentration dropped abruptly at the begin-
ning in the three groups and then remained un-
changed. The differences were really important
between the first and the second period (p < Ö.05)
but there was no significant difference between
the second and third periods (Fig. 2).
Tab. I. Gestational age in weeks (mean and range) for
the three groups
Group I
Group II
Group III
Number
of cases
11
10
11
Mean
(weeks)
34
32
40
Range
(weeks)
27-36 (*)
28-36 (*)
38-41
(*) Non significant between Group I and Group II
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Tab. II. Secretory IgA concentration in grams/liter for the three groups in each period
4-5 days 8-10 days 14-15 days
Mean Range n Mean Range n Mean Range
Group I
(Preterm without medication)
Group II
(Preterm with medication)
Group III
Full term
11
10
11
2.03
3.17
2.56
0.96-5.35
1.55-5.35
1.55-8.17
8
9
8
1.55
2.03
1.57
1.14-2.56
1.55-5.35
0.79-3.49
9
8
6
1.14
1.47
1.24
1.04-4.98
0.96-2.03
0.79-3.83
4 Discussion
The secretory IgA is the most concentrated
immunoglobulin in human milk and provides it
with anti-infection properties against a great
variety of germs. Owing to its physical and chemi-
cal structure it is not affected by either digestive
juices or pH changes. The quantification of milk
secretory IgA, is a difficult technical problem and
many kinds of methods have been used.
The previous mentioned values in human milk are
expressed in different ways. These have been
reported in arbitrary units, mg/g protein [15],
g/1 [10, 12] and mg/ml [5]. Our values are expres-
sed in g/1, and they are quite similar to those
reported by HANSON et al. [10] and GOLDMAN
et al. [5].
We have not found differences in concentration in
mothers with a full term delivery when compared
with those who had a preterm delivery, having or
having not received drugs. The same was found for
colostrum, transitional and mature milk. This is a
very important fact since drugs administered for
the acceleration of pulmonary maturity and
inhibition of uterine contractility in preterm labor
would not produce modification in the secretory
IgA concentration in maternal milk. This latter
fact has not yet been pointed out regarding con-
centrations in preterm mother's milk.
Other authors, such as GROSS et al. [7] and LUCAS
et al. [12] have found that the IgA secretory con-
centration is greater in preterm mothers. We have
not been able to confirm this in our study. These
authors do not mention whether the mothers were
given any kind of medication.
According to the present study, it may be stated
that glucocorticoid and betamimetic administra-
tion has no effects on the secretory IgA concentra-
tion in maternal milk.
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Fig. 1. IgA secretory concentration in milk from mothers
with full and preterm delivery. There are no differences
between the groups in the three periods.
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Fig. 2. The IgA secretory concentration is significantly
greater in colostrum than in transitional milk. Between
the latter and mature milk there are no differences.
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Supporting the statements of other authors [1, 2, requirements could be met with milk from their
3, 5, 7, 8, 9, 12, 14], we may conclude that the own mothers. It therefore would be unnecessary
preterm infant's nutritional and immunological to give formula or bank milk.
Summary
A prospective study was performed to find the possible
difference in secretory IgA concentration in milk of
mothers with term pregnancy labors and those deliver-
ing at earlier gestational ages. Since tocolytic drugs
and/or glucocorticoid agents are usually given in cases of
threatened premature labor, the pre-term group was
divided into mothers with or without medication.
Thirty two mothers were distributed in three groups:
Group I, mothers with preterm labors without any
medication; Group II, preterm labors with previous treat-
Nment with betamimetics and glucocorticoids; Group III,
term labors (see Tab. I). In each of the three groups,
three periods were studied: colostral (4 to 5 days post-
partum), transitional (8 to 10 days), and mature (14 to
15 days). All mothers were healthy, with good nutritional
state, without local inflammation and membranes had
been ruptured 12 hours or less before labor. There was no
significant difference in the proportion of primiparas
and multiparas in both groups. The gestational age was
evaluated by amenorrhea and neonatal examination. In all
mothers milk was extracted with a vacuum pump to
empty the mammary gland. The determinations were
made using a specific antibody against the secretory com-
ponent. The concentration of free secretory component
in these milks was practically insignificant.
No differences were found in the concentration of secre-
tory IgA among the three groups (Tab. II, Fig. 1) in the
periods that were studied, colostral, transitional or
mature. The farther away from labor that milk extrac-
tion was made, in the periods considered in our study,
there is a progressive decrease in the concentration of
secretory IgA (Fig. 2).
No evidence has been found showing that medication
given to the mother during the hours before delivery
affects the concentration of secretory IgA in milk. This
knowledge, together with other information previously
described regarding composition of preterm mother's
milk, supports the statement that preterm neonates may
be fed with their own mother's milk.
Keywords: Betamimetics, glucocorticoids, human milk, preterm, secretory IgA.
Zusammenfassung
Einfluß von Corticoiden und Betamimetika auf die
Konzentration von sekretorischem IgA in der Milch bei
Müttern nach Frühgeburten
Wir führten eine prospektive Untersuchung mit folgender
Fragestellung durch: gibt es Unterschiede zwischen den
Konzentrationen von sekretorischem IgA in der Milch von
Müttern mit Geburten am Termin und Müttern nach Früh-
geburten? Da bei drohender Frühgeburt normalerweise
wehenhemmende Mittel und/oder Corticoide verabreicht
werden, mußte in der Frühgeburtengruppe weiter unter-
schieden werden zwischen Patientinnen mit und ohne
Medikation.
32 Mütter wurden in 3 Gruppen aufgeteilt; Gruppe I: Patien-
tinnen mit Frühgeburten ohne Medikation; Gruppe II:
Frauen mit Frühgeburten, die vorher Betamimetika und
Glucocorticoide erhalten hatten; Gruppe III: Frauen mit
Geburten am Termin (Tab. I). In allen 3 Gruppen wurden
3 Phasen untersucht, in denen eine unterschiedliche Milch
produziert wird: das Kolostrum (4-5 Tage p.p.), die
Übergangsmilch (8-10 Tage p.p.) und die reife Milch
(14-15 Tag p.p.). Alle Mütter waren gesund und in einem
guten Ernährungszustand. Es lagen keine lokalen Ent-
zündungszeichen vor und der Blasensprung war innerhalb
von 12 Stunden ante partum erfolgt. Das Verhältnis von
Schlüsselwörter: Betamimetika, Corticoide, Frauenmilch, Frühgeburt, sekretorisches IgA.
Ers.t- und Mehrgebärenden war in beiden Gruppen mit-
einander vergleichbar. Das Gestationsalter wurde durch
die Dauer der Amenorrhoe sowie den neonatalen Reife-
zustand festgelegt. Die Milch wurde mit Vakuum abge-
pumpt, um so die Brustdrüse zu entleeren. Zur Konzentra-
tionsmessung wurde ein spezifischer Antikörper gegen die
sekretorische IgA-Komponente benutzt. Die Konzentra-
tion von freien sekretorischen IgA-Anteilen war bei allen
Milchformen praktisch zu vernachlässigen. Zwischen allen
3 Gruppen gab es bezüglich der Konzentration von sekre-
torischen IgA innerhalb der einzelnen Phasen (Kolostrum,
Übergangsmilch und reife Milch) keine Unterschiede
(Tab. II, Fig. 1). Wir konnten feststellen, daß über unseren
Beobachtungszeitraum das sekretorische IgA stetig abfiel,
d.h., je länger die Geburt zurücklag, um so niedriger war
das sekretorische IgA (Fig. 2).
Wir fanden keinen Anhalt dafür, daß eine der Geburt vor-
angegangene Medikation der Mutter die Konzentration
von sekretorischem IgA beeinflußt. In früheren Arbeiten
wurde die Zusammensetzung der Milch von Müttern nach
Frühgeburten beschrieben. Das Ergebnis der vorliegenden
Arbeit unterstützt die Forderung, daß Frühgeborene
Muttermilch erhalten sollen.
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Resume
Influence des cortico'ides et des betamimetiques sur la
concentration des IgA secretoires dans le lait des meres
d'enfants prematures
On a realise une etude prospective pour trouver une
difference possible entre la concentration des IgA secre-
toires dans le lait des meres ayant accouche ä terme et des
meres ayant accouche ä des termes gestationnels plus
precoces.
En raison du fait que utilise habituellement des
medicaments utero-relaxants et/ou des corticoides en cas
de menace d'accouchement premature, le groupe pre-
mature a ete subdivise en meres traitees et non-traitees.
Trente-deux meres ont ete reparties en trois groupes:
groupe I, meres avec accouchement premature sans
traitement; groupe II, accouchement premature avec
traitement anterieur par betamimetiques et cortico'ides;
groupe III, accouchement ä terme (Tab. I). Dans les
trois groupes, on a etudie trois periodes: colostrale (4 ä
5 jours); transitionnelle (8 ä 10 jours) et mature (14 a
15 jours).
Toutes les meres etaient bien portantes, avec un bon
equilibre nutritionnel, sans inflammation locale et avec
une rupture des membranes inferieure ou egale ä 12
heures. II n'y a pas eu de difference significative dans la
proportion de primipares et de multipares entre chaque
groupe. L'äge gestationnel a ete determine par la duree de
Famenorrhee et Fexamen neonatal. Chez toutes les meres,
le lait a ete extrait ä Faide d'une pompe ä aspiration afin
de vider la glande mammaire. L'analyse a ete effectuee ä
Faide d'un anticorps specifique contre les composants
secretoires. La concentration des composants secretoires
libres dans ces laits etait pratiquement insignificante.
On n'a pas trouve de difference dans la concentration des
IgA secretoires entre les 3 groupes (Tab. II, Fig. 1), au
cours des 3 periodes etudiees, colostrale, transitionnelle
et mature. Aussi longtemps que Fon a poursuivi les
prelevements de lait apres Faccouchement, il y a eu dans
les periodes de notre etude une diminution progressive de
la concentration des IgA secretoires (Fig. 2).
On n'a pas trouve d'arguments en faveur d'un retentisse-
ment des medications donnees ä la mere au cours des
heures precedant Faccouchement sur la concentration
d'IgA secretoires dans le lait.
Cette connaissance, jointe aux autres informations pre-
alablement decrites sur la composition du lait des meres
d'enfants prematures, conforte Fidee que les nouveaux-
nes prematures doivent etre nourris a Faide du lait de leurs
propres meres'
Mots-cles: Accouchement premature, betamimetiques, cortico'ides, IgA secretaire, lait humain.
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Despite more than a century of ever-increasing scientific interest and research,
anorexia nervosa - the pathological pursuit of thinness - still presents a chal-
lenge to clinicians throughout the world. It has become practically impossible to
keep in touch with the constant proliferation of scientific literature on this sub-
ject. Moreover, the clinician (the general practitioner, the psychiatrist or the psy-
chologist) needs, first and foremost, practical guidelines for his everyday thera-
peutic work with these patients.
Therefore, two experienced clinicians, who are daily involved in research and
treatment of large numbers of anorexia nervosa patients, decided to write the
first book dealing extensively with the many practical issues one is faced with
when investigating and treating anorectic patients of all ages and in all stages of
their illness. No single treatment modality, psychotherapeutic, pharmacologic or
nutritional, has provided the final solution for the management of this intriguing
syndrome. Hence, the therapeutic approach described in this book is characte-
rized as an eclectic, broad spectrum or multimodal treatment in which strate-
gies and interventions from different therapeutic models have been integrated.
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